alexa Tumour Associated Antigens Which Act As Biomarkers Of Survival And Targets For Immunotherapy In Acute Myeloid Leukaemia
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th International Conference on Vaccines & Vaccination
September 24-26, 2014 Valencia Convention Centre, Spain

Barbara Guinn
Accepted Abstracts: J Vaccines Vaccin
DOI: 10.4172/2157-7560.S1.022
Abstract
W e have used a number of techniques to identify tumour antigens recognized by the immune system of acute myeloid leukaemia (AML) patients including RT-PCR, SEREX, protein and cDNA arrays. We identified synovial sarcoma X breakpoint 2-interacting protein (SSX2IP) as a biomarker for survival. We analyzed 312 presentation AML samples and segregated AML patients based on above- and below-median levels of expression of SSX2IP. Analysis of Kaplan-Meier curves showed a significant association between elevated SSX2IP expression and improved survival times in AML patients who lacked detectable cytogenetic abnormalities (log-rank test, n=180; P=0.007). We have also identified the cancer-testis antigen PASD1 through the immunoscreening of a testes cDNA library with pooled AML patient sera. We identified a number of algorithm- selected naturally occurring 9 amino acid peptides which could bind HLA-A*0201 however these peptides failed to show detectable MHC binding in T2 assays. We modified one of the two anchor residues and showed these analogue peptides had enhanced binding, with decreased off-rates, in T2 assays. T cells from patients and normal donors responded to analogue peptide-loaded antigen presenting cells by secreting IFN γ . For clinical application, a DNA fusion gene vaccine encoding Pa14 was designed and tested in ?humanized? mice. Splenocytes from vaccinated mice showed in vitro cytoxicity against tumor cells, either exogenously loaded with the corresponding wild type peptide (Pw8) or expressing endogenously processed PASD1 protein. We show for the first time that a DNA vaccine encoding an altered PASD1 epitope can induce CTL able to target the natural peptide expressed by human tumor cells
Biography
Barbara Guinn completed her PhD in Medicine in 1995 from University of Wales College of Medicine, Cardiff. Her Postdoctoral studies were performed at the University of Toronto. She is an Associate Professor at the University of Bedfordshire and Academic Director for Undergraduate Life Science. She is also the Editor- in-Chief of Biomarkers in Cancer, Senior Editor of Vaccines and Vaccinations, and has published more than 70 manuscripts in peer review journals. In addition she has served as a reviewer on an ad hoc basis for more than 35 journals and more than 10 national and international funding bodies.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords